1,532
Views
14
CrossRef citations to date
0
Altmetric
Retracted Article

RETRACTED ARTICLE: Belinostat suppresses cell proliferation by inactivating Wnt/β-catenin pathway and promotes apoptosis through regulating PKC pathway in breast cancer

, , , , &
Pages 3955-3960 | Received 28 Apr 2019, Accepted 10 Aug 2019, Published online: 01 Oct 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Lovekesh Mehta, Tanveer Naved, Parul Grover, Monika Bhardwaj, Debaraj Mukherjee & Dushyanth R. Vennapu. (2021) Identification and characterization of new degradation products of belinostat using UHPLC-Q-TOF-MS/MS and in silico toxicity prediction. Journal of Liquid Chromatography & Related Technologies 44:5-6, pages 285-297.
Read now

Articles from other publishers (13)

Forough Firoozbakht, Iman Rezaeian, Luis Rueda & Alioune Ngom. (2022) Computationally repurposing drugs for breast cancer subtypes using a network-based approach. BMC Bioinformatics 23:1.
Crossref
Jianwei Feng & Xinyue Meng. (2022) Histone modification and histone modification-targeted anti-cancer drugs in breast cancer: Fundamentals and beyond. Frontiers in Pharmacology 13.
Crossref
Xiaoshuo Dai, Xinhuan Chen, Wei Chen, Yihuan Chen, Jun Zhao, Qiushuang Zhang & Jing Lu. (2022) A Pan-cancer Analysis Reveals the Abnormal Expression and Drug Sensitivity of CSF1. Anti-Cancer Agents in Medicinal Chemistry 22:7, pages 1296-1312.
Crossref
Colleen E. Quaas & David T. Long. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology 469 492 .
Milad Ashrafizadeh, Hossein Rafiei, Reza Mohammadinejad, Tahereh Farkhondeh & Saeed Samarghandian. (2021) Anti-tumor activity of resveratrol against gastric cancer: a review of recent advances with an emphasis on molecular pathways. Cancer Cell International 21:1.
Crossref
Jiancheng Lv, Ping-an Chang, Xin Li, Xiao Yang, Jie Han, Hao Yu, Zijian Zhou, Haiwei Yang, Pengchao Li, Jiexiu Zhang & Qiang Lu. (2021) Identification of the circRNA-miRNA-mRNA Regulatory Network in Bladder Cancer by Bioinformatics Analysis. International Journal of Genomics 2021, pages 1-22.
Crossref
Devesh Tewari, Sweta Bawari, Shikha Sharma, Lindsay K. DeLiberto & Anupam Bishayee. (2021) Targeting the crosstalk between canonical Wnt/β-catenin and inflammatory signaling cascades: A novel strategy for cancer prevention and therapy. Pharmacology & Therapeutics 227, pages 107876.
Crossref
Wei Li, Hao Wu, Shiyao Sui, Qin Wang, Shouping Xu & Da Pang. (2021) Targeting Histone Modifications in Breast Cancer: A Precise Weapon on the Way. Frontiers in Cell and Developmental Biology 9.
Crossref
Jian Ouyang, Zilong Liu, Xiaobing Yuan, Chunping Long, Xia Chen, Yongpeng Wang, Lu Liu, Shaohua Liu & Hui Liang. (2021) LncRNA PRNCR1 Promotes Breast Cancer Proliferation and Inhibits Apoptosis by Modulating microRNA-377/CCND2/MEK/MAPK Axis. Archives of Medical Research 52:5, pages 471-482.
Crossref
Vivek Kumar, Mohit Vashishta, Lin Kong, Xiaodong Wu, Jiade J. Lu, Chandan Guha & B. S. Dwarakanath. (2021) The Role of Notch, Hedgehog, and Wnt Signaling Pathways in the Resistance of Tumors to Anticancer Therapies. Frontiers in Cell and Developmental Biology 9.
Crossref
Giedrė Valiulienė, Aida Vitkevičienė & Rūta Navakauskienė. (2020) The epigenetic treatment remodel genome-wide histone H4 hyper-acetylation patterns and affect signaling pathways in acute promyelocytic leukemia cells. European Journal of Pharmacology 889, pages 173641.
Crossref
Christopher Hillyar, Kathrine S Rallis & Jajini Varghese. (2020) Advances in Epigenetic Cancer Therapeutics. Cureus.
Crossref
Ziyue Yao, Yu Chen, Wenhua Cao & Ng Shyh‐Chang. (2020) Chromatin‐modifying drugs and metabolites in cell fate control. Cell Proliferation 53:11.
Crossref